| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.59▲ | 4.60▲ | 4.63▼ | 4.69▼ | 4.04▲ |
| MA10 | 4.59▲ | 4.64▼ | 4.64▼ | 4.66▼ | 3.89▲ |
| MA20 | 4.61▲ | 4.64▼ | 4.69▼ | 4.06▲ | 2.51▲ |
| MA50 | 4.65▼ | 4.69▼ | 4.68▼ | 3.70▲ | 1.69▲ |
| MA100 | 4.65▼ | 4.69▼ | 4.42▲ | 2.42▲ | 1.55▲ |
| MA200 | 4.72▼ | 4.32▲ | 3.84▲ | 1.79▲ | 6.24▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.004▼ | -0.010▼ | 0.026▲ | 0.229▲ |
| RSI | 51.040▲ | 46.044▼ | 46.259▼ | 63.077▲ | 70.466▲ |
| STOCH | 51.716 | 13.480▼ | 26.954 | 61.286 | 46.158 |
| WILL %R | -35.000 | -69.767 | -74.510 | -33.333 | -39.085 |
| CCI | 109.465▲ | -96.804 | -108.352▼ | 38.609 | 90.586 |
|
Thursday, May 07, 2026 03:48 PM
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, ...
|
|
Thursday, May 07, 2026 03:48 PM
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, ...
|
|
Friday, April 10, 2026 09:40 AM
Detailed price information for An2 Therapeutics Inc (ANTX-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/05/26 | 4.65 | 4.78 | 4.54 | 4.60 | 149,328 |
| 06/05/26 | 4.73 | 4.82 | 4.598 | 4.65 | 182,402 |
| 05/05/26 | 4.82 | 5.17 | 4.69 | 4.69 | 317,637 |
| 04/05/26 | 4.66 | 4.88 | 4.57 | 4.85 | 326,095 |
| 01/05/26 | 4.55 | 4.87 | 4.43 | 4.68 | 106,567 |
| 30/04/26 | 4.68 | 4.68 | 4.43 | 4.55 | 125,607 |
| 29/04/26 | 4.74 | 4.85 | 4.57 | 4.68 | 177,523 |
| 28/04/26 | 4.78 | 5.03 | 4.61 | 4.74 | 268,898 |
| 27/04/26 | 4.32 | 5.11 | 4.32 | 4.80 | 618,657 |
| 24/04/26 | 4.30 | 4.44 | 4.01 | 4.34 | 236,581 |
|
|
||||
|
|
||||
|
|